The future of the next generation sequencing market looks promising with opportunities in academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The global next generation sequencing market is expected to grow with a CAGR of 20% to 22% from 2021 to 2026. The major drivers for this market are government regulations and reimbursement for NGS-based diagnostic tests, advancements in NGS platforms, and declining costs of NGS tests.
A more than 150 page report is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of next generation sequencing market report download the report brochure.